48 related articles for article (PubMed ID: 22178383)
1. Perturbing mitosis for anti-cancer therapy: is cell death the only answer?
Haschka M; Karbon G; Fava LL; Villunger A
EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29459486
[TBL] [Abstract][Full Text] [Related]
2. Modeling Cancer Cell Growth Dynamics
Lorz A; Botesteanu DA; Levy D
Front Oncol; 2017; 7():189. PubMed ID: 28913178
[TBL] [Abstract][Full Text] [Related]
3. A mitotic stopwatch determines cell fate.
Bertolin AP; Gottifredi V
Science; 2024 Mar; 383(6690):1414-1415. PubMed ID: 38547295
[TBL] [Abstract][Full Text] [Related]
4. Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-X
Beltrán-Visiedo M; Jiménez-Alduán N; Díez R; Cuenca M; Benedi A; Serrano-Del Valle A; Azaceta G; Palomera L; Peperzak V; Anel A; Naval J; Marzo I
Mol Oncol; 2023 Dec; 17(12):2507-2525. PubMed ID: 37704591
[TBL] [Abstract][Full Text] [Related]
5. 6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.
Du S; Sarver JG; Trabbic CJ; Erhardt PW; Schroering A; Maltese WA
Cancer Chemother Pharmacol; 2019 Feb; 83(2):237-254. PubMed ID: 30426158
[TBL] [Abstract][Full Text] [Related]
6. Universal response in the RKO colon cancer cell line to distinct antimitotic therapies.
Lorz A; Botesteanu DA; Levy D
Sci Rep; 2018 Jun; 8(1):8979. PubMed ID: 29895957
[TBL] [Abstract][Full Text] [Related]
7. Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.
Chan A; Gilfillan C; Templeton N; Paterson I; Northcote PT; Miller JH
Invest New Drugs; 2017 Dec; 35(6):706-717. PubMed ID: 28733703
[TBL] [Abstract][Full Text] [Related]
8. Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer.
Mittal K; Donthamsetty S; Kaur R; Yang C; Gupta MV; Reid MD; Choi DH; Rida PCG; Aneja R
Br J Cancer; 2017 Apr; 116(9):1186-1194. PubMed ID: 28334734
[TBL] [Abstract][Full Text] [Related]
9. Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma.
Havas AP; Rodrigues KB; Bhakta A; Demirjian JA; Hahn S; Tran J; Scavello M; Tula-Sanchez AA; Zeng Y; Schmelz M; Smith CL
Cancer Biol Ther; 2016 Dec; 17(12):1240-1252. PubMed ID: 27791595
[TBL] [Abstract][Full Text] [Related]
10. Prenylated Chalcone 2 Acts as an Antimitotic Agent and Enhances the Chemosensitivity of Tumor Cells to Paclitaxel.
Fonseca J; Marques S; Silva PM; Brandão P; Cidade H; Pinto MM; Bousbaa H
Molecules; 2016 Jul; 21(8):. PubMed ID: 27483224
[TBL] [Abstract][Full Text] [Related]
11. Coating Solid Lipid Nanoparticles with Hyaluronic Acid Enhances Antitumor Activity against Melanoma Stem-like Cells.
Shen H; Shi S; Zhang Z; Gong T; Sun X
Theranostics; 2015; 5(7):755-71. PubMed ID: 25897340
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of indolyl-pyridinyl-propenones having either methuosis or microtubule disruption activity.
Trabbic CJ; Overmeyer JH; Alexander EM; Crissman EJ; Kvale HM; Smith MA; Erhardt PW; Maltese WA
J Med Chem; 2015 Mar; 58(5):2489-512. PubMed ID: 25654321
[TBL] [Abstract][Full Text] [Related]
13. A novel submicron emulsion system loaded with vincristine-oleic acid ion-pair complex with improved anticancer effect: in vitro and in vivo studies.
Zhang T; Zheng Y; Peng Q; Cao X; Gong T; Zhang Z
Int J Nanomedicine; 2013; 8():1185-96. PubMed ID: 23658485
[TBL] [Abstract][Full Text] [Related]
14. Cell fate after mitotic arrest in different tumor cells is determined by the balance between slippage and apoptotic threshold.
Galán-Malo P; Vela L; Gonzalo O; Calvo-Sanjuán R; Gracia-Fleta L; Naval J; Marzo I
Toxicol Appl Pharmacol; 2012 Feb; 258(3):384-93. PubMed ID: 22178383
[TBL] [Abstract][Full Text] [Related]
15. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.
Chen YC; Lu PH; Pan SL; Teng CM; Kuo SC; Lin TP; Ho YF; Huang YC; Guh JH
Biochem Pharmacol; 2007 Jun; 74(1):10-9. PubMed ID: 17475221
[TBL] [Abstract][Full Text] [Related]
16. Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents.
Sánchez-Pérez T; Ortiz-Ferrón G; López-Rivas A
Cell Death Differ; 2010 May; 17(5):883-94. PubMed ID: 19942932
[TBL] [Abstract][Full Text] [Related]
17. Bcl-xL blocks high dose doxorubicin-induced apoptosis but not low dose doxorubicin-induced cell death through mitotic catastrophe.
Park SS; Kim MA; Eom YW; Choi KS
Biochem Biophys Res Commun; 2007 Nov; 363(4):1044-9. PubMed ID: 17923112
[TBL] [Abstract][Full Text] [Related]
18. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.
Roninson IB; Broude EV; Chang BD
Drug Resist Updat; 2001 Oct; 4(5):303-13. PubMed ID: 11991684
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cancer cell survival by BCL2 family members upon prolonged mitotic arrest: opportunities for anticancer therapy.
Barillé-Nion S; Bah N; Véquaud E; Juin P
Anticancer Res; 2012 Oct; 32(10):4225-33. PubMed ID: 23060542
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
